Hope for ALS: phase 3 trial of pridopidine aims to slow disease
NCT ID NCT07322003
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 18 times
Summary
This phase 3 trial tests if the drug pridopidine can slow the progression of ALS, a serious nerve disease. About 500 adults with ALS will take either pridopidine or a placebo daily for 48 weeks, followed by an open-label period where everyone gets the drug. Researchers will measure changes in physical function and survival to see if the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Genge Partners
RECRUITINGMontreal, Quebec, H4P 2N2, Canada
Contact Email: •••••@•••••
-
Sean M. Healey & AMG Center for ALS
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Somnos Clinical Research
RECRUITINGLincoln, Nebraska, 68506, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Texas Neurology
RECRUITINGDallas, Texas, 75206, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kansas
RECRUITINGFairway, Kansas, 66205, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.